Alyeska Investment Group
TBRA

Alyeska Investment Group’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Alyeska Investment Group’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-12,109
Closed -$740K – 516
2014
Q2 		$740K Sell
12,109
-27,345
-69% -$1.66M 0.02% 367
2014
Q1 		$4.45M Buy
39,454
+26,563
+206% +$1.86M 0.12% 210
2013
Q4 		$553K Buy
12,891
+5,556
+76% +$261K 0.02% 283
2013
Q3 		$442K Buy
+7,335
New +$384K 0.02% 288

Other funds holding TBRA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Alyeska Investment Group's TBRA Position: Q3 2014 in Review

Alyeska Investment Group sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q3 2014, closing a stake of 12,109 shares — an estimated $740K sold.

Alyeska Investment Group first reported a position in TBRA in Q3 2013 and held it in 4 quarters. The position peaked at $4.45M in Q1 2014. 47 funds tracked by Wall St. Rank hold TBRA as of Q3 2014.

  • Alyeska Investment Group reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • Alyeska Investment Group sold 12,109 Tobira Therapeutics, Inc. Common Stock shares in Q3 2014, an estimated $740K.
  • Alyeska Investment Group first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2013 and held it in 4 quarters.
  • Alyeska Investment Group's Tobira Therapeutics, Inc. Common Stock position peaked at $4.45M in Q1 2014.
  • 47 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q3 2014.

Based on Alyeska Investment Group's 13F filing for Q3 2014, filed 14 Nov 2014.